SNP55, a new functional polymorphism of MDM2-P2 promoter, contributes to allele-specific expression of MDM2 in endometrial cancers
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2350
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
SNP55, a new functional polymorphism of MDM2-P2 promoter, contributes to allele-specific expression of MDM2 in endometrial cancers ; volume:16 ; number:1 ; day:21 ; month:8 ; year:2015 ; pages:1-15 ; date:12.2015
BMC medical genetics ; 16, Heft 1 (21.8.2015), 1-15, 12.2015
- Creator
-
Okamoto, Kanako
- Contributor
-
Tsunematsu, Ryosuke
Tahira, Tomoko
Sonoda, Kenzo
Asanoma, Kazuo
Yagi, Hiroshi
Yoneda, Tomoko
Hayashi, Kenshi
Wake, Norio
Kato, Kiyoko
SpringerLink (Online service)
- DOI
-
10.1186/s12881-015-0216-8
- URN
-
urn:nbn:de:1111-201611057403
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:01 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Okamoto, Kanako
- Tsunematsu, Ryosuke
- Tahira, Tomoko
- Sonoda, Kenzo
- Asanoma, Kazuo
- Yagi, Hiroshi
- Yoneda, Tomoko
- Hayashi, Kenshi
- Wake, Norio
- Kato, Kiyoko
- SpringerLink (Online service)
Other Objects (12)
Impact of the MDM2 splice-variants MDM2-A, MDM2-B and MDM2-C on cytotoxic stress response in breast cancer cells
The MDM2 gene family
Inhibition of MDM2 homodimerization by XIAP IRES stabilizes MDM2, influencing cancer cell survival
Allele-specific binding (ASB) analyzer for annotation of allele-specific binding SNPs
MDM2 as a chromatin modifier
MDM2 SNP309 polymorphism contributes to endometrial cancer susceptibility: evidence from a meta-analysis
Targeting p53–MDM2 interaction by small-molecule inhibitors: learning from MDM2 inhibitors in clinical trials
MDM2- an indispensable player in tumorigenesis
Evolution of the p53-MDM2 pathway
MDM2 promoter polymorphism del1518 (rs3730485) and its impact on endometrial and ovarian cancer risk
Allele-specific expression assays using Solexa
Allele-specific disparity in breast cancer
Impact of the MDM2 splice-variants MDM2-A, MDM2-B and MDM2-C on cytotoxic stress response in breast cancer cells
The MDM2 gene family
Inhibition of MDM2 homodimerization by XIAP IRES stabilizes MDM2, influencing cancer cell survival
Allele-specific binding (ASB) analyzer for annotation of allele-specific binding SNPs
MDM2 as a chromatin modifier
MDM2 SNP309 polymorphism contributes to endometrial cancer susceptibility: evidence from a meta-analysis
Targeting p53–MDM2 interaction by small-molecule inhibitors: learning from MDM2 inhibitors in clinical trials
MDM2- an indispensable player in tumorigenesis
Evolution of the p53-MDM2 pathway
MDM2 promoter polymorphism del1518 (rs3730485) and its impact on endometrial and ovarian cancer risk
Allele-specific expression assays using Solexa
Allele-specific disparity in breast cancer
Impact of the MDM2 splice-variants MDM2-A, MDM2-B and MDM2-C on cytotoxic stress response in breast cancer cells
The MDM2 gene family
Inhibition of MDM2 homodimerization by XIAP IRES stabilizes MDM2, influencing cancer cell survival
Allele-specific binding (ASB) analyzer for annotation of allele-specific binding SNPs
MDM2 as a chromatin modifier
MDM2 SNP309 polymorphism contributes to endometrial cancer susceptibility: evidence from a meta-analysis
Targeting p53–MDM2 interaction by small-molecule inhibitors: learning from MDM2 inhibitors in clinical trials
MDM2- an indispensable player in tumorigenesis
Evolution of the p53-MDM2 pathway
MDM2 promoter polymorphism del1518 (rs3730485) and its impact on endometrial and ovarian cancer risk
Allele-specific expression assays using Solexa